TrialClinical pharmacokinetics2023

Safety, Pharmacokinetics, and Pharmacodynamics of SHR7280, a Non-peptide GnRH Antagonist in Premenopausal Women with Endometriosis: A Randomized, Double-Blind, Placebo-Controlled Phase 1 Study.

Yuan Li et al.PubMed ↗Publisher ↗

No numbers read from the abstract.